T cell responses to synthetic TSH receptor peptides in Graves' disease
- 1 September 1992
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 89 (3) , 468-473
- https://doi.org/10.1111/j.1365-2249.1992.tb06982.x
Abstract
SUMMARY: Twenty-eight peptides, representing the entire extracellular domain of the TSH receptor, were synthesised to investigate which parts of this autoantigen may be targets for the T cell response in Graves' disease (GD). T cells from 11 of 21 controls and 26 of 36 newly diagnosed GD patients proliferated in response to one or more peptides with a stimulation index (SI) of > 2·0 (χ2 = 2·31, P > 0·1). The response of patients and controls to any of the individual peptides was also not statistically different. However, individual patients gave high SIs with certain peptides to which controls either gave an absent or very weak response. HLA-DR3 was not associated with any particular response to TSHR peptides. Three out of seven GD patients whose T cells were evaluated before and after treatment showed a response of this kind only early in the course of their disease. Intrathyroidal T cells from four GD patients did not give a consistent proliferative response to pools of five peptides, and depleting peripheral blood T cells of their CD8+ population did not affect the proliferative response. These results indicate that the T cell response to the TSH receptor in GD does not seem to be directed against any one particular epitope on the peptides we have tested which cover the extracellular domain.Keywords
This publication has 31 references indexed in Scilit:
- A synthetic oligopeptide derived from human thyrotropin receptor sequence binds to Graves' immunoglobulin and inhibits thyroid stimulating antibody activity but lacks interactions with TSHBiochemical and Biophysical Research Communications, 1991
- T-cell reactivity to 38 kD insulin-secretory-granule protein in patients with recent-onset type 1 diabetesThe Lancet, 1991
- Possible binding site of thyrotropin binding inhibitor immunoglobulin (TBII) on the thyrotropin (TSH) receptor, which is different from TSH binding siteBiochemical and Biophysical Research Communications, 1990
- Identification of immunogenic regions in human thyrotropin receptor for immunoglobulin G of patients with Graves' diseaseBiochemical and Biophysical Research Communications, 1990
- Cloning, sequencing and expression of human TSH receptorBiochemical and Biophysical Research Communications, 1990
- Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: Evidence for binding of autoantibodiesBiochemical and Biophysical Research Communications, 1989
- Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptorBiochemical and Biophysical Research Communications, 1989
- Autologous CD8-positive cells suppress T cell proliferation in response to thyroid antigens in Hashimoto's thyroiditisClinical Immunology and Immunopathology, 1989
- DNA-RFLP analysis and genotyping of HLA-DR and DQ antigensImmunology Today, 1988
- The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditisClinical Immunology and Immunopathology, 1986